LKB1 inactivation in KRAS mutant lung cancer cells enhances glycolysis and serine biosynthesis and protects cell survival from serine deprivation through deregulated AMPK-mTORC1 signaling (Kottakis et al., 2016). Here, KRAS is linked to lung carcinoma.